Researchers in cancer biology and oncology research

Paul Calabresi

Paul Calabresi (1930–2003) was an Italian-born American physician-scientist and pioneer of medical oncology who served as Brown University's first Chairman of Medicine and advised national cancer policy.

Paul E. Neiman

Paul E. Neiman (1939–2017) was an American physician-scientist and founding faculty member of Fred Hutchinson Cancer Research Center who studied retroviruses and oncogenes in chickens.

Paul G. Richardson

Paul G. Richardson is an American hematologist-oncologist at Dana-Farber Cancer Institute and Harvard Medical School whose clinical trials established standard multiple myeloma drugs, including bortezomib and lenalidomide.

Paul J. Hesketh

Paul J. Hesketh is an American medical oncologist who directs the Lahey Cancer Institute in Massachusetts and shaped the prevention of chemotherapy-induced nausea and vomiting.

Paul M. Hwang

Paul M. Hwang is an American physician-scientist who leads the Cardiovascular and Cancer Genetics laboratory at the National Heart, Lung, and Blood Institute, studying p53 and mitochondrial metabolism in cancer.

Paul M. Lieberman

Paul M. Lieberman is an American virologist and epigenetics researcher at The Wistar Institute in Philadelphia who studies latent Epstein-Barr virus infection and EBNA1 inhibitors.

Paul P. Carbone

Paul P. Carbone was an American medical oncologist who helped develop MOPP and CMF chemotherapy, led ECOG, shared the 1972 Lasker Award, and directed the UW Comprehensive Cancer Center.

Paul Workman (cancer pharmacologist)

Paul Workman is a cancer pharmacologist and chemical biologist at the Institute of Cancer Research, London, known for kinase and Hsp90 inhibitors and the Pharmacological Audit Trail.

Pavan Reddy

Pavan Reddy is an Indian-born American hematologist-oncologist directing the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, known for research on graft-versus-host disease.

Per Hall

Per Hall is a Swedish medical oncologist and professor of radiation epidemiology at Karolinska Institutet who studies breast-cancer genetics and risk-based screening, and founded the KARMA mammography cohort in 2010.

Peter B. Becker

Peter B. Becker (Peter Becker) is a molecular biologist who studies chromatin dynamics and dosage compensation, and was Professor of Molecular Biology at LMU Munich from 1999 to 2026.

Peter Besmer

Peter Besmer (1940–2024) was a Swiss-born cancer biologist at Memorial Sloan Kettering who worked out Kit receptor biology and built the first GIST mouse models.

Peter Brian Bach

Peter Brian Bach (Peter B. Bach) is an American physician and health policy researcher known for work on cancer drug pricing, Medicare policy, and lung cancer screening.

Peter C. Brooks

Peter C. Brooks is an American angiogenesis and cancer biologist who leads a laboratory at MaineHealth Institute for Research in Scarborough, Maine, and teaches at Tufts.

Peter C. Nowell̀

Peter C. Nowell (1928–2016) was an American physician-scientist and cancer cytogeneticist at the University of Pennsylvania who co-discovered the Philadelphia chromosome and won the 1998 Lasker Award.

Peter Dirks

Peter B. Dirks is a Canadian neurosurgeon and cancer stem-cell biologist at SickKids in Toronto, best known for identifying cancer stem cells in human brain tumors in 2003 and 2004.

Peter J. Campbell

Peter J. Campbell is a British cancer genomics researcher who coined chromothripsis and kataegis, headed the Sanger Institute's Cancer, Ageing and Somatic Mutation program, and left in 2024 for Quotient Therapeutics.

Peter J. O’Dwyer

Peter J. O'Dwyer is a medical oncologist, professor of medicine at the University of Pennsylvania, and co-chair of ECOG-ACRIN, known for gastrointestinal cancer research and the NCI-MATCH precision medicine trial.

Peter J. Polverini

Peter J. Polverini is an American oral and maxillofacial pathologist and cancer researcher who served as dean of the University of Michigan School of Dentistry from 2003 to 2013.

Peter J. Selby

Peter J. Selby is a British oncologist and Professor of Cancer Medicine at the University of Leeds, known for the acyclovir studies and the MRC Myeloma VII trial.

Peter John Campbell

Peter John Campbell is a cancer genomicist and clinician-scientist known for chromothripsis, kataegis, and mutational signatures, who led the Cancer, Ageing and Somatic Mutation program at the Wellcome Sanger Institute.

Peter Johnson (medical oncologist)

Peter Johnson, also known as Peter M. Johnson, is a British medical oncologist at the University of Southampton known for the RAPID trial in Hodgkin lymphoma.

Peter L. Stern

Peter L. Stern, also known as Peter Stern, is a cancer immunologist and Group Leader at the University of Manchester, known for discovering the 5T4 oncofoetal antigen.

Peter Lichter

Peter Lichter is a German cancer geneticist who headed Molecular Genetics at the German Cancer Research Center in Heidelberg and developed FISH and array-CGH into standard cancer research tools.

Peter M. Glazer

Peter M. Glazer is an American radiation oncologist and physician-scientist who chairs the Department of Therapeutic Radiology at Yale, known for research on DNA repair, tumor hypoxia, and gene editing.

Peter M. Howley

Peter M. Howley is an American virologist and pathologist, the Shattuck Professor at Harvard Medical School, known for showing how high-risk HPV oncoproteins disable tumor suppressor pathways.

Peter R. Holt

Peter R. Holt (1930–2024) was a Berlin-born American gastroenterologist known for Whipple's disease research and colorectal cancer prevention, and a Columbia University professor of medicine.

Peter S. Nelson

Peter S. Nelson is an American medical oncologist and cancer genomics researcher at Fred Hutch Cancer Center in Seattle, specializing in inherited risk for advanced prostate cancer.

Peter Sasieni

Peter Sasieni is a British cancer epidemiologist and biostatistician, Professor at Queen Mary University of London, whose research reshaped NHS cervical screening and quantified HPV vaccination's impact.